Janne Janne Lehtiö Karolinska Institutet and SciLifeLab Sweden

Janne Lehtiö is professor of medical proteomics at KI with position as clinical chemist at the Karolinska Univ. Hospital. Lehtiö’s group has pioneered proteogenomics by integrating genomics, transcriptomics, and proteomics to uncover new coding regions in the human genome and decode cancer-specific molecular mechanisms by combined development of in-depth proteomics and computational methods. Lately he has focused on systems medicine focusing on topological proteome-network analysis for combination treatment selection. Beyond basic research, Lehtiö team has developed the Molecular Tumor Board Portal, a digital clinical decision support tool used in large European precision oncology trials to guide patient treatment based on personal omics data. He is currently leading Precision Medicine and Diagnostics area in Data Driven Life Science Program, a national program hosted by SciLifeLab and financed by KAW foundation. He is a member of the Nobel Assembly for Medicine or Physiology at Karolinska Institutet and board of directors at Karolinska Comprehensive Cancer Center and Cancer Core Europe as well as chairing Proteome Medicine Sweden, a governmentally finances innovation environment.

Monday 08 June 2026

Time Session
14:00
15:15
Joint EACR - EACS - Molecular Oncology Session: The Dark Proteome
Siddhi Maniyar Co-Chair FEBS PressUnited Kingdom
YardenaSamuels Co-Chair Weizmann Institute of ScienceIsrael
Room F1+2+3

Wednesday 10 June 2026

Time Session
14:30
15:15
Olink, part of Thermo Fisher Scientific sponsored Industry Symposium: Advancing Cancer Research Beyond Genomics with Plasma Proteomics
Proteomics is gaining increasing attention in cancer research by providing functional insights beyond genomics and driving novel biomarker discovery. This symposium highlights how high-throughput proteomics enables a deeper understanding of tumor biology, early detection, and treatment response.
Room F9+10